The Organization for Economic Cooperation and Development has issued projections that indicate China will overtake Japan by the end of 2006 as the world's second largest R&D investor. The USA remains the clear global leader in this area with $330.0 billion R&D spending versus China's forecast $136.0 billion.
Since 1995, R&D spending as a percentage of Gross Domestic Product is estimated to have doubled to 1.2%, in a period when the economy has grown an average 9%-10% per year.
The OECD also calculates that Japan will spend $130.0 billion and the European Union's 15 members (before 2004 enlargement) $230.0 billion on R&D respectively.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze